Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does PALBOCICLIB Cause Blood creatinine increased? 485 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 485 reports of Blood creatinine increased have been filed in association with PALBOCICLIB (Ibrance). This represents 0.5% of all adverse event reports for PALBOCICLIB.

485
Reports of Blood creatinine increased with PALBOCICLIB
0.5%
of all PALBOCICLIB reports
38
Deaths
150
Hospitalizations

How Dangerous Is Blood creatinine increased From PALBOCICLIB?

Of the 485 reports, 38 (7.8%) resulted in death, 150 (30.9%) required hospitalization, and 28 (5.8%) were considered life-threatening.

Is Blood creatinine increased Listed in the Official Label?

Yes, Blood creatinine increased is listed as a known adverse reaction in the official FDA drug label for PALBOCICLIB.

What Other Side Effects Does PALBOCICLIB Cause?

Fatigue (15,190) White blood cell count decreased (11,273) Neoplasm progression (10,885) Death (8,410) Nausea (8,189) Neutropenia (6,423) Alopecia (6,201) Diarrhoea (5,635) Asthenia (3,660) Off label use (3,405)

What Other Drugs Cause Blood creatinine increased?

EMTRICITABINE\TENOFOVIR DISOPROXIL (1,966) TENOFOVIR DISOPROXIL (1,460) TACROLIMUS (1,439) METHOTREXATE (1,401) SACUBITRIL\VALSARTAN (1,389) RITUXIMAB (1,265) EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL (1,112) METFORMIN (986) ECULIZUMAB (967) LENALIDOMIDE (959)

Which PALBOCICLIB Alternatives Have Lower Blood creatinine increased Risk?

PALBOCICLIB vs PALIPERIDONE PALBOCICLIB vs PALIVIZUMAB PALBOCICLIB vs PALONOSETRON PALBOCICLIB vs PAMIDRONATE PALBOCICLIB vs PAMIDRONIC ACID

Related Pages

PALBOCICLIB Full Profile All Blood creatinine increased Reports All Drugs Causing Blood creatinine increased PALBOCICLIB Demographics